Antibiotic Resistance Crisis
Antimicrobial resistance threatens to render modern antibiotics ineffective, potentially causing 10 million deaths annually by 2050. Current drug development pipelines are insufficient to replace failing treatments.
The Humans
Every human on Earth is at risk. 1.27M die annually from drug-resistant infections. Hospitals face untreatable superbugs. Developing nations are hit hardest — India, Nigeria, Pakistan see the most deaths. Farmers overusing antibiotics in livestock accelerate resistance.
Customer Segments
Capital Progress
23% funded10/10 Framework
6.8/10 avgSeverity × scale × urgency.
Quality and quantity of teams working on it.
How close we are to viable solutions.
Market demand and customer pull.
Business model viability.
Organizations Working on This (4)
Making healthcare accessible to 150M+ people
$480B market capFighting the global obesity and diabetes epidemic
$380B market capSolving infectious disease with programmable medicine
$44B market capDecoding the human genome to cure genetic diseases
$20B market capPeople Solving This
Meaningful Work
Opportunities at organizations working on this problem.
Programming medicine to cure diseases thought incurable
Using data to save lives at the scale of entire populations
Making whole genome sequencing accessible to every patient
Curing the epidemic affecting 1 billion people worldwide
Learn From the Best
From David Senra's Founders podcast - church for entrepreneurs.
The most prolific vaccine developer in history - saved more lives than any other scientist.
“The greatest impact comes from solving problems most people don't even see.”
A surgeon's examination of how medicine fails the people it is supposed to help.
“The best solutions require understanding the full human experience of the problem.”
Want to Work on This Problem?
Discover how your passions and talents match this problem.